期刊
EXPERT OPINION ON DRUG DISCOVERY
卷 12, 期 9, 页码 941-953出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/17460441.2017.1344400
关键词
Drug discovery; hybrid compounds; immune system; nitric oxide; nitric oxide synthase inhibitors; NO-donors; prodrugs; therapeutic potential
资金
- Sao Paulo Research Foundation (FAPESP)
- Coordination for the Improvement of Higher Education Personnel (CAPES)
- Brazilian National Council for Scientific and Technological Development (CNPq)
- CNPq [309989/2015-9]
- FAPESP [2016/03124-0]
- CAPES
- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [16/03124-0] Funding Source: FAPESP
Introduction: There is a great interest in Nitric oxide (NO) within medicinal chemistry since it's involved in human signaling pathways. Prodrugs or hybrid compounds containing NO-donor scaffolds linked to an active compound are valuable, due to their potential for modulating many pathological conditions due to NO's biological properties when released in addition to the native drug. Compounds that selectively inhibit nitric oxide synthase isoforms (NOS) can also increase therapeutic capacity, particularly in the treatment of chronic diseases. However, search for bioactive compounds to efficiently and selectively modulate NO is still a challenge in drug discovery. Areas covered: In this review, the authors highlight the recent advances in the strategies used to discover NO-hybrid derivatives, especially those related to anti-inflammatory, cardiovascular, anticancer and anti-microorganism activities. They also focus on: nitric oxide synthase inhibitors, NO delivery materials and other related activities. Expert opinion: The process of molecular hybridization can be used to obtain NO-releasing compounds that also interact with different targets. The main problem with this approach is to control NO multiple actions in the right biological system. However, the use of NO-releasing groups with many different scaffolds leads to new molecular structures for bioactive compounds, suggesting synergies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据